| UniProt ID | SART3_HUMAN | |
|---|---|---|
| UniProt AC | Q15020 | |
| Protein Name | Squamous cell carcinoma antigen recognized by T-cells 3 {ECO:0000305} | |
| Gene Name | SART3 {ECO:0000312|HGNC:HGNC:16860} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 963 | |
| Subcellular Localization | Nucleus, nucleoplasm . Nucleus, Cajal body . Nucleus speckle . Cytoplasm . | |
| Protein Description | U6 snRNP-binding protein that functions as a recycling factor of the splicing machinery. Promotes the initial reassembly of U4 and U6 snRNPs following their ejection from the spliceosome during its maturation. [PubMed: 12032085 Also binds U6atac snRNPs and may function as a recycling factor for U4atac/U6atac spliceosomal snRNP, an initial step in the assembly of U12-type spliceosomal complex. The U12-type spliceosomal complex plays a role in the splicing of introns with non-canonical splice sites] | |
| Protein Sequence | MATAAETSASEPEAESKAGPKADGEEDEVKAARTRRKVLSRAVAAATYKTMGPAWDQQEEGVSESDGDEYAMASSAESSPGEYEWEYDEEEEKNQLEIERLEEQLSINVYDYNCHVDLIRLLRLEGELTKVRMARQKMSEIFPLTEELWLEWLHDEISMAQDGLDREHVYDLFEKAVKDYICPNIWLEYGQYSVGGIGQKGGLEKVRSVFERALSSVGLHMTKGLALWEAYREFESAIVEAARLEKVHSLFRRQLAIPLYDMEATFAEYEEWSEDPIPESVIQNYNKALQQLEKYKPYEEALLQAEAPRLAEYQAYIDFEMKIGDPARIQLIFERALVENCLVPDLWIRYSQYLDRQLKVKDLVLSVHNRAIRNCPWTVALWSRYLLAMERHGVDHQVISVTFEKALNAGFIQATDYVEIWQAYLDYLRRRVDFKQDSSKELEELRAAFTRALEYLKQEVEERFNESGDPSCVIMQNWARIEARLCNNMQKARELWDSIMTRGNAKYANMWLEYYNLERAHGDTQHCRKALHRAVQCTSDYPEHVCEVLLTMERTEGSLEDWDIAVQKTETRLARVNEQRMKAAEKEAALVQQEEEKAEQRKRARAEKKALKKKKKIRGPEKRGADEDDEKEWGDDEEEQPSKRRRVENSIPAAGETQNVEVAAGPAGKCAAVDVEPPSKQKEKAASLKRDMPKVLHDSSKDSITVFVSNLPYSMQEPDTKLRPLFEACGEVVQIRPIFSNRGDFRGYCYVEFKEEKSALQALEMDRKSVEGRPMFVSPCVDKSKNPDFKVFRYSTSLEKHKLFISGLPFSCTKEELEEICKAHGTVKDLRLVTNRAGKPKGLAYVEYENESQASQAVMKMDGMTIKENIIKVAISNPPQRKVPEKPETRKAPGGPMLLPQTYGARGKGRTQLSLLPRALQRPSAAAPQAENGPAAAPAVAAPAATEAPKMSNADFAKLFLRK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MATAAETSA ------CCCHHCCCC | 13.12 | 20068231 | |
| 3 | Phosphorylation | -----MATAAETSAS -----CCCHHCCCCC | 25.71 | 21955146 | |
| 7 | Phosphorylation | -MATAAETSASEPEA -CCCHHCCCCCCCHH | 25.51 | 23401153 | |
| 8 | Phosphorylation | MATAAETSASEPEAE CCCHHCCCCCCCHHH | 22.69 | 29255136 | |
| 10 | Phosphorylation | TAAETSASEPEAESK CHHCCCCCCCHHHHH | 54.15 | 29255136 | |
| 16 | Phosphorylation | ASEPEAESKAGPKAD CCCCHHHHHCCCCCC | 34.55 | 29255136 | |
| 48 | Phosphorylation | RAVAAATYKTMGPAW HHHHHHHHHCCCCCH | 10.35 | - | |
| 130 | Ubiquitination | RLEGELTKVRMARQK HHCCHHHHHHHHHHH | 40.23 | - | |
| 130 | Ubiquitination | RLEGELTKVRMARQK HHCCHHHHHHHHHHH | 40.23 | - | |
| 130 | 2-Hydroxyisobutyrylation | RLEGELTKVRMARQK HHCCHHHHHHHHHHH | 40.23 | - | |
| 208 | Phosphorylation | GGLEKVRSVFERALS CCHHHHHHHHHHHHH | 33.86 | 24719451 | |
| 215 | Phosphorylation | SVFERALSSVGLHMT HHHHHHHHHCCCHHH | 23.22 | 23186163 | |
| 216 | Phosphorylation | VFERALSSVGLHMTK HHHHHHHHCCCHHHH | 22.51 | 24719451 | |
| 221 | Sulfoxidation | LSSVGLHMTKGLALW HHHCCCHHHHHHHHH | 5.08 | 21406390 | |
| 246 | 2-Hydroxyisobutyrylation | VEAARLEKVHSLFRR HHHHHHHHHHHHHHH | 50.25 | - | |
| 294 | Ubiquitination | KALQQLEKYKPYEEA HHHHHHHHCCCHHHH | 68.14 | 21890473 | |
| 294 | Ubiquitination | KALQQLEKYKPYEEA HHHHHHHHCCCHHHH | 68.14 | 21890473 | |
| 294 (in isoform 1) | Ubiquitination | - | 68.14 | 21890473 | |
| 294 (in isoform 2) | Ubiquitination | - | 68.14 | 21890473 | |
| 295 | Phosphorylation | ALQQLEKYKPYEEAL HHHHHHHCCCHHHHH | 14.07 | 28152594 | |
| 296 | Ubiquitination | LQQLEKYKPYEEALL HHHHHHCCCHHHHHH | 52.79 | - | |
| 298 | Phosphorylation | QLEKYKPYEEALLQA HHHHCCCHHHHHHHC | 23.42 | 28152594 | |
| 341 | Glutathionylation | ERALVENCLVPDLWI HHHHHHCCCCCCHHH | 2.28 | 22555962 | |
| 350 | Phosphorylation | VPDLWIRYSQYLDRQ CCCHHHHHHHHHCCC | 7.32 | 19835603 | |
| 351 | Phosphorylation | PDLWIRYSQYLDRQL CCHHHHHHHHHCCCC | 11.51 | 19835603 | |
| 353 | Phosphorylation | LWIRYSQYLDRQLKV HHHHHHHHHCCCCCH | 12.48 | 19835603 | |
| 356 | Methylation | RYSQYLDRQLKVKDL HHHHHHCCCCCHHHH | 40.93 | 115493369 | |
| 361 | 2-Hydroxyisobutyrylation | LDRQLKVKDLVLSVH HCCCCCHHHHHHHHH | 43.70 | - | |
| 435 | Ubiquitination | LRRRVDFKQDSSKEL HHHCCCCCCCCHHHH | 49.05 | - | |
| 435 | 2-Hydroxyisobutyrylation | LRRRVDFKQDSSKEL HHHCCCCCCCCHHHH | 49.05 | - | |
| 446 | Methylation | SKELEELRAAFTRAL HHHHHHHHHHHHHHH | 27.44 | 115493357 | |
| 455 | Ubiquitination | AFTRALEYLKQEVEE HHHHHHHHHHHHHHH | 21.76 | - | |
| 457 | Acetylation | TRALEYLKQEVEERF HHHHHHHHHHHHHHH | 43.44 | 26051181 | |
| 491 | Ubiquitination | RLCNNMQKARELWDS HHHCCHHHHHHHHHH | 38.35 | - | |
| 501 | Phosphorylation | ELWDSIMTRGNAKYA HHHHHHHHHCCHHHH | 33.48 | 29496963 | |
| 502 | Methylation | LWDSIMTRGNAKYAN HHHHHHHHCCHHHHH | 20.98 | 115493363 | |
| 506 | Acetylation | IMTRGNAKYANMWLE HHHHCCHHHHHHHHH | 49.23 | 7366827 | |
| 532 | Ubiquitination | QHCRKALHRAVQCTS HHHHHHHHHHHHCCC | 22.10 | 21890473 | |
| 532 | Acetylation | QHCRKALHRAVQCTS HHHHHHHHHHHHCCC | 22.10 | - | |
| 541 | Phosphorylation | AVQCTSDYPEHVCEV HHHCCCCCHHHHHHH | 15.41 | 22817900 | |
| 550 | Ubiquitination | EHVCEVLLTMERTEG HHHHHHHHEEECCCC | 5.31 | - | |
| 555 | Phosphorylation | VLLTMERTEGSLEDW HHHEEECCCCCHHHH | 31.24 | 28122231 | |
| 558 | Phosphorylation | TMERTEGSLEDWDIA EEECCCCCHHHHHHH | 23.50 | 28122231 | |
| 568 | Acetylation | DWDIAVQKTETRLAR HHHHHHHHHHHHHHH | 41.55 | 23236377 | |
| 568 (in isoform 1) | Ubiquitination | - | 41.55 | 21890473 | |
| 568 | Malonylation | DWDIAVQKTETRLAR HHHHHHHHHHHHHHH | 41.55 | 26320211 | |
| 568 | Ubiquitination | DWDIAVQKTETRLAR HHHHHHHHHHHHHHH | 41.55 | 2190698 | |
| 586 | Malonylation | QRMKAAEKEAALVQQ HHHHHHHHHHHHHHH | 48.18 | 26320211 | |
| 586 | Acetylation | QRMKAAEKEAALVQQ HHHHHHHHHHHHHHH | 48.18 | 25953088 | |
| 586 | Ubiquitination | QRMKAAEKEAALVQQ HHHHHHHHHHHHHHH | 48.18 | - | |
| 643 | Acetylation | DEEEQPSKRRRVENS CCCCCCCHHHHHHHC | 57.52 | 26051181 | |
| 650 | Phosphorylation | KRRRVENSIPAAGET HHHHHHHCCCCCCCC | 19.22 | 25849741 | |
| 657 | Phosphorylation | SIPAAGETQNVEVAA CCCCCCCCCCEEEEE | 25.24 | 29978859 | |
| 679 | Phosphorylation | AVDVEPPSKQKEKAA EEECCCCCHHHHHHH | 59.44 | 28555341 | |
| 687 | Phosphorylation | KQKEKAASLKRDMPK HHHHHHHHHCCCCCH | 39.00 | 24719451 | |
| 694 | Ubiquitination | SLKRDMPKVLHDSSK HHCCCCCHHHCCCCC | 51.28 | - | |
| 703 | Phosphorylation | LHDSSKDSITVFVSN HCCCCCCCEEEEECC | 24.72 | 20068231 | |
| 705 | Phosphorylation | DSSKDSITVFVSNLP CCCCCCEEEEECCCC | 16.31 | 20068231 | |
| 709 | Phosphorylation | DSITVFVSNLPYSMQ CCEEEEECCCCCCCC | 22.61 | 20068231 | |
| 713 | Phosphorylation | VFVSNLPYSMQEPDT EEECCCCCCCCCCCC | 21.68 | 20068231 | |
| 714 | Phosphorylation | FVSNLPYSMQEPDTK EECCCCCCCCCCCCC | 16.43 | 20068231 | |
| 720 | Phosphorylation | YSMQEPDTKLRPLFE CCCCCCCCCCHHHHH | 42.57 | 20068231 | |
| 740 | Phosphorylation | VQIRPIFSNRGDFRG EEEEECCCCCCCCCC | 26.74 | - | |
| 754 | Acetylation | GYCYVEFKEEKSALQ CEEEEEECHHHHHHH | 52.00 | 26822725 | |
| 765 | Sulfoxidation | SALQALEMDRKSVEG HHHHHHHHCCCCCCC | 6.67 | 21406390 | |
| 769 | Phosphorylation | ALEMDRKSVEGRPMF HHHHCCCCCCCCCEE | 26.71 | 23401153 | |
| 778 | Phosphorylation | EGRPMFVSPCVDKSK CCCCEEEECCCCCCC | 11.00 | 29496963 | |
| 794 | Phosphorylation | PDFKVFRYSTSLEKH CCCCEEEEECCHHHC | 12.58 | 26657352 | |
| 795 | Phosphorylation | DFKVFRYSTSLEKHK CCCEEEEECCHHHCC | 13.78 | 25159151 | |
| 796 | Phosphorylation | FKVFRYSTSLEKHKL CCEEEEECCHHHCCE | 28.53 | 25159151 | |
| 797 | Phosphorylation | KVFRYSTSLEKHKLF CEEEEECCHHHCCEE | 28.70 | 23312004 | |
| 822 | Ubiquitination | EELEEICKAHGTVKD HHHHHHHHHHCCHHH | 49.43 | - | |
| 831 | Ubiquitination | HGTVKDLRLVTNRAG HCCHHHHHHHHCCCC | 36.93 | - | |
| 831 | Methylation | HGTVKDLRLVTNRAG HCCHHHHHHHHCCCC | 36.93 | 115493351 | |
| 834 | Phosphorylation | VKDLRLVTNRAGKPK HHHHHHHHCCCCCCC | 24.47 | - | |
| 852 | Phosphorylation | YVEYENESQASQAVM EEEECCHHHHHHHHH | 42.50 | 17525332 | |
| 867 | Ubiquitination | KMDGMTIKENIIKVA HHCCCEEEHHHHHHH | 35.23 | - | |
| 889 | Phosphorylation | KVPEKPETRKAPGGP CCCCCCCCCCCCCCC | 46.10 | - | |
| 906 | Methylation | LPQTYGARGKGRTQL CCCCCCCCCCCHHHH | 42.89 | 24129315 | |
| 906 | Dimethylation | LPQTYGARGKGRTQL CCCCCCCCCCCHHHH | 42.89 | - | |
| 908 | Methylation | QTYGARGKGRTQLSL CCCCCCCCCHHHHHH | 39.40 | 115368095 | |
| 911 | Phosphorylation | GARGKGRTQLSLLPR CCCCCCHHHHHHHHH | 42.40 | 21964256 | |
| 914 | Phosphorylation | GKGRTQLSLLPRALQ CCCHHHHHHHHHHHC | 20.31 | 21406692 | |
| 918 | Methylation | TQLSLLPRALQRPSA HHHHHHHHHHCCCCC | 48.15 | 54559081 | |
| 922 | Ubiquitination | LLPRALQRPSAAAPQ HHHHHHCCCCCCCCC | 28.17 | - | |
| 924 | Phosphorylation | PRALQRPSAAAPQAE HHHHCCCCCCCCCCC | 32.50 | 21406692 | |
| 946 | O-linked_Glycosylation | AVAAPAATEAPKMSN CCCCCCCCCCCCCCC | 34.48 | 28411811 | |
| 946 | Phosphorylation | AVAAPAATEAPKMSN CCCCCCCCCCCCCCC | 34.48 | 21406692 | |
| 958 | Ubiquitination | MSNADFAKLFLRK-- CCCHHHHHHHCCC-- | 39.50 | 21890473 | |
| 958 (in isoform 1) | Ubiquitination | - | 39.50 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SART3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SART3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SART3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 175900 | Disseminated superficial actinic porokeratosis 1 (DSAP1) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-8 AND SER-10, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7; SER-8 AND SER-10, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-8 AND SER-10, AND MASS SPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-852, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10 AND SER-16, AND MASSSPECTROMETRY. | |